Lapol

Lansoprazole, the active ingredient in Lapol, is a proton pump inhibitor presented as an oral tablet for systemic use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Helicobacter pylori eradication therapy. GNH USA supplies Lapol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid‑secretion pathway and is used for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing by maintaining a less acidic gastric environment. - Helicobacter pylori eradication: used in combination regimens to improve bacterial clearance. - Erosive esophagitis: reduces acid exposure, allowing mucosal recovery.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually self‑limiting. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with fever. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use if severe impairment is present. - Review concomitant medications: potential for interaction with drugs requiring acidic pH. - Monitor for infection: prolonged acid suppression may increase gastrointestinal infection risk. - Evaluate bone health: consider calcium and vitamin D supplementation for long‑term users. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lansoprazole can affect the absorption and metabolism of several medicines.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced efficacy due to increased gastric pH. - Antifungal agents (e.g., ketoconazole, itraconazole): markedly decreased absorption. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate (high dose): reduced clearance, watch for toxicity. - Digoxin: altered absorption, check serum levels.